Moderna Inc. buy UBS Group AG
Start price
19.02.25
/
50%
€34.80
Target price
19.02.26
€74.74
Performance (%)
-23.68%
Price
30.12.25
€26.56
Summary
This prediction is currently active. The price of Moderna Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.68%. This prediction currently runs until 19.02.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | -3.030% | -3.030% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $96.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat